International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

New Resource Page on Generalized Pustular Psoriasis

BI Resource Page on GPP graphic

Generalized Pustular Psoriasis (GPP) is a rare, lifelong skin disease that may be life-threatening if left untreated. It is characterized by flares that appear suddenly in the form of painful, pus-filled blisters over large body parts. It may be accompanied by more general symptoms, such as fever, headache, extreme tiredness, or a burning sensation on the skin. GPP can be confused with the more common plaque psoriasis, but they are distinct diseases.

Boehringer Ingelheim has created a resource page that includes the latest articles, downloads, and related press releases on GPP to assist with diagnosing and treating this rare disease.


Recent Posts

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Mona El-Kalioby, MBBCh, MSc, MD

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

Boehringer Ingelheim’s SPEVIGO® Receives Breakthrough Therapy Designation (BTD) from the United States Food and Drug Administration (FDA)

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.